Bavarian Nordic A/S

private

Total Raised

Contracts

$1,264,240,981

1 award of $10M+

Patents

PAC Giving

Government Contracts & Awards

BAVARIAN NORDIC A/S: IGF::OT::IGF

$1,264,240,981

Award Office of Assistant Secretary for Preparedness and Response Aug 24, 2017

Proprietary Tech & Patents

A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus Disease

US 12746282 Sep 29, 2026

Form D Funding

No recent SEC Form D filings found.

Market Intelligence & News

Yahoo Sep 17, 2026

Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin whose departure was announced earlier this year. Tarja Stenvall is a global healthcare executive with over 20 years of leadership experience from Sanofi, AstraZeneca, and Pfizer, combining deep commercial expertise with a proven track record of building and transforming businesse

Key People

No individuals linked to this entity yet.

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro